Technology
Health
Pharmaceutical

Gossamer Bio

$17.78
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.22 (-1.22%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Gossamer Bio and other stocks, options, ETFs, and crypto commission-free!

About GOSS

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate is GB001, which is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. Read More The company was founded by Faheem Hasnain and Sheila Gujrathi in 2015 and is headquartered in San Diego, CA.

Employees
119
Headquarters
San Diego, California
Founded
2015
Market Cap
1.17B
Price-Earnings Ratio
Dividend Yield
Average Volume
214.31K
High Today
$18.54
Low Today
$17.54
Open Price
$18.06
Volume
190.01K
52 Week High
$25.06
52 Week Low
$15.59

Collections

Technology
Health
Pharmaceutical
Therapy
2019 IPO
US
North America
Female CEOs

GOSS Earnings

-$0.90
-$0.79
-$0.67
-$0.56
Q1 2019
Q2 2019
Estimated
-$0.56 per share
Actual
-$0.74 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.